These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25088745)

  • 1. The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver.
    Patel K; Foretz M; Marion A; Campbell DG; Gourlay R; Boudaba N; Tournier E; Titchenell P; Peggie M; Deak M; Wan M; Kaestner KH; Göransson O; Viollet B; Gray NS; Birnbaum MJ; Sutherland C; Sakamoto K
    Nat Commun; 2014 Aug; 5():4535. PubMed ID: 25088745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes.
    Itoh Y; Sanosaka M; Fuchino H; Yahara Y; Kumagai A; Takemoto D; Kagawa M; Doi J; Ohta M; Tsumaki N; Kawahara N; Takemori H
    J Biol Chem; 2015 Jul; 290(29):17879-17893. PubMed ID: 26048985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
    Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
    J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling.
    Miller RA; Chu Q; Le Lay J; Scherer PE; Ahima RS; Kaestner KH; Foretz M; Viollet B; Birnbaum MJ
    J Clin Invest; 2011 Jun; 121(6):2518-28. PubMed ID: 21606593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIK1 Regulates CRTC2-Mediated Gluconeogenesis Signaling Pathway in Human and Mouse Liver Cells.
    Wang C; Song D; Fu J; Wen X
    Front Endocrinol (Lausanne); 2020; 11():580. PubMed ID: 33013689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.
    Shaw RJ; Lamia KA; Vasquez D; Koo SH; Bardeesy N; Depinho RA; Montminy M; Cantley LC
    Science; 2005 Dec; 310(5754):1642-6. PubMed ID: 16308421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of SIK1 by phanginin A inhibits hepatic gluconeogenesis by increasing PDE4 activity and suppressing the cAMP signaling pathway.
    Liu S; Huang S; Wu X; Feng Y; Shen Y; Zhao QS; Leng Y
    Mol Metab; 2020 Nov; 41():101045. PubMed ID: 32599076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes.
    Wang Y; Li G; Goode J; Paz JC; Ouyang K; Screaton R; Fischer WH; Chen J; Tabas I; Montminy M
    Nature; 2012 Apr; 485(7396):128-32. PubMed ID: 22495310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
    Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
    J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity.
    Qiao A; Ma W; Jiang Y; Han C; Yan B; Zhou J; Qin G
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
    Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
    World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lkb1 suppresses amino acid-driven gluconeogenesis in the liver.
    Just PA; Charawi S; Denis RGP; Savall M; Traore M; Foretz M; Bastu S; Magassa S; Senni N; Sohier P; Wursmer M; Vasseur-Cognet M; Schmitt A; Le Gall M; Leduc M; Guillonneau F; De Bandt JP; Mayeux P; Romagnolo B; Luquet S; Bossard P; Perret C
    Nat Commun; 2020 Nov; 11(1):6127. PubMed ID: 33257663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
    Nixon M; Stewart-Fitzgibbon R; Fu J; Akhmedov D; Rajendran K; Mendoza-Rodriguez MG; Rivera-Molina YA; Gibson M; Berglund ED; Justice NJ; Berdeaux R
    Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin and thiazolidinedione targets CRTC2 to regulate hepatic gluconeogenesis.
    Yoon YS; Ryu D; Lee MW; Hong S; Koo SH
    Exp Mol Med; 2009 Aug; 41(8):577-83. PubMed ID: 19381067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salt-inducible kinase 2 and -3 are downregulated in adipose tissue from obese or insulin-resistant individuals: implications for insulin signalling and glucose uptake in human adipocytes.
    Säll J; Pettersson AM; Björk C; Henriksson E; Wasserstrom S; Linder W; Zhou Y; Hansson O; Andersson DP; Ekelund M; Degerman E; Stenkula KG; Laurencikiene J; Göransson O
    Diabetologia; 2017 Feb; 60(2):314-323. PubMed ID: 27807598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPKα-like proteins as LKB1 downstream targets in cell physiology and cancer.
    Molina E; Hong L; Chefetz I
    J Mol Med (Berl); 2021 May; 99(5):651-662. PubMed ID: 33661342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHD3 regulates glucose metabolism by suppressing stress-induced signalling and optimising gluconeogenesis and insulin signalling in hepatocytes.
    Yano H; Sakai M; Matsukawa T; Yagi T; Naganuma T; Mitsushima M; Iida S; Inaba Y; Inoue H; Unoki-Kubota H; Kaburagi Y; Asahara SI; Kido Y; Minami S; Kasuga M; Matsumoto M
    Sci Rep; 2018 Sep; 8(1):14290. PubMed ID: 30250231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicle-stimulating hormone enhances hepatic gluconeogenesis by GRK2-mediated AMPK hyperphosphorylation at Ser485 in mice.
    Qi X; Guo Y; Song Y; Yu C; Zhao L; Fang L; Kong D; Zhao J; Gao L
    Diabetologia; 2018 May; 61(5):1180-1192. PubMed ID: 29442133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
    Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
    J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone-induced Krüppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia.
    Cui A; Fan H; Zhang Y; Zhang Y; Niu D; Liu S; Liu Q; Ma W; Shen Z; Shen L; Liu Y; Zhang H; Xue Y; Cui Y; Wang Q; Xiao X; Fang F; Yang J; Cui Q; Chang Y
    J Clin Invest; 2019 Apr; 129(6):2266-2278. PubMed ID: 31033478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.